| Product Code: ETC7624822 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Benign Prostatic Hyperplasia Treatment Devices Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Benign Prostatic Hyperplasia Treatment Devices Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Benign Prostatic Hyperplasia Treatment Devices Market - Industry Life Cycle |
3.4 Ireland Benign Prostatic Hyperplasia Treatment Devices Market - Porter's Five Forces |
3.5 Ireland Benign Prostatic Hyperplasia Treatment Devices Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.6 Ireland Benign Prostatic Hyperplasia Treatment Devices Market Revenues & Volume Share, By Product, 2021 & 2031F |
4 Ireland Benign Prostatic Hyperplasia Treatment Devices Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of benign prostatic hyperplasia (BPH) in the aging population in Ireland |
4.2.2 Technological advancements in BPH treatment devices leading to improved efficacy and safety |
4.2.3 Rising awareness among patients and healthcare providers about minimally invasive treatment options for BPH |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for the approval of BPH treatment devices in Ireland |
4.3.2 High cost associated with acquiring and maintaining BPH treatment devices |
4.3.3 Limited reimbursement options for BPH treatment devices in the healthcare system of Ireland |
5 Ireland Benign Prostatic Hyperplasia Treatment Devices Market Trends |
6 Ireland Benign Prostatic Hyperplasia Treatment Devices Market, By Types |
6.1 Ireland Benign Prostatic Hyperplasia Treatment Devices Market, By Treatment |
6.1.1 Overview and Analysis |
6.1.2 Ireland Benign Prostatic Hyperplasia Treatment Devices Market Revenues & Volume, By Treatment, 2021- 2031F |
6.1.3 Ireland Benign Prostatic Hyperplasia Treatment Devices Market Revenues & Volume, By Minimal Invasive Surgery, 2021- 2031F |
6.1.4 Ireland Benign Prostatic Hyperplasia Treatment Devices Market Revenues & Volume, By Invasive Surgery, 2021- 2031F |
6.2 Ireland Benign Prostatic Hyperplasia Treatment Devices Market, By Product |
6.2.1 Overview and Analysis |
6.2.2 Ireland Benign Prostatic Hyperplasia Treatment Devices Market Revenues & Volume, By Resectoscopes, 2021- 2031F |
6.2.3 Ireland Benign Prostatic Hyperplasia Treatment Devices Market Revenues & Volume, By Urology Laser, 2021- 2031F |
6.2.4 Ireland Benign Prostatic Hyperplasia Treatment Devices Market Revenues & Volume, By Radiofrequency Ablation, 2021- 2031F |
6.2.5 Ireland Benign Prostatic Hyperplasia Treatment Devices Market Revenues & Volume, By Electrodes, 2021- 2031F |
6.2.6 Ireland Benign Prostatic Hyperplasia Treatment Devices Market Revenues & Volume, By Catheters, 2021- 2031F |
6.2.7 Ireland Benign Prostatic Hyperplasia Treatment Devices Market Revenues & Volume, By Prostatic Stents, 2021- 2031F |
7 Ireland Benign Prostatic Hyperplasia Treatment Devices Market Import-Export Trade Statistics |
7.1 Ireland Benign Prostatic Hyperplasia Treatment Devices Market Export to Major Countries |
7.2 Ireland Benign Prostatic Hyperplasia Treatment Devices Market Imports from Major Countries |
8 Ireland Benign Prostatic Hyperplasia Treatment Devices Market Key Performance Indicators |
8.1 Adoption rate of minimally invasive BPH treatment procedures in Ireland |
8.2 Rate of complications associated with BPH treatment devices |
8.3 Patient satisfaction and quality of life improvement post-treatment with BPH devices |
9 Ireland Benign Prostatic Hyperplasia Treatment Devices Market - Opportunity Assessment |
9.1 Ireland Benign Prostatic Hyperplasia Treatment Devices Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.2 Ireland Benign Prostatic Hyperplasia Treatment Devices Market Opportunity Assessment, By Product, 2021 & 2031F |
10 Ireland Benign Prostatic Hyperplasia Treatment Devices Market - Competitive Landscape |
10.1 Ireland Benign Prostatic Hyperplasia Treatment Devices Market Revenue Share, By Companies, 2024 |
10.2 Ireland Benign Prostatic Hyperplasia Treatment Devices Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here